GynTect

Schnell zu einer sicheren Diagnose

Die Neuheit für Diagnostiklabore

GynTect.

GynTect.

Sichere Diagnose

Sie haben Fragen zu GynTect?

Wir helfen weiter!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

Newsletter

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

News

oncgnostics in Kuba 2020privat: Dr. Alfred Hansel

Cervical cancer screening in Cuba

During the first days of March, Dr. Alfred Hansel took a close look at the healthcare system of Cuba. The Managing Director of oncgnostics GmbH participated in the Cuban-German Healthtech Summit in Havana. Cervical cancer and its early detection…
Shutterstock

Human papillomaviruses (HPV) – What is it?

Human papillomaviruses are a group of widespread viruses. In most cases, people affected by the virus are unaware of the infection. However, certain types of HPV are responsible for the development of tumours, such as cervical cancer. Almost…
oncgnostics GmbH

Sepsis: In which Patients does the Immune System Break Down?

As part of a new EU consortium, Oncgnostics GmbH is investigating diagnostic possibilities of immune collapse after sepsis. More than 140 people die every day in Germany of sepsis, commonly known as blood poisoning. Two thirds of them do not…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.